What is the dosing for cadexomer (iodine) in treating infected venous stasis ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cadexomer Iodine Dosing for Infected Venous Stasis Ulcers

Apply cadexomer iodine to the affected ulcer area 1 to 3 times daily after cleaning the wound, and cover with a sterile bandage after allowing it to dry first. 1

Application Technique

  • Clean the affected ulcer area thoroughly before each application 1
  • Apply a small amount of cadexomer iodine directly to the ulcer surface 1 to 3 times daily 1
  • Allow the preparation to dry before covering with a sterile bandage 1
  • Change dressings daily, which can be performed by patients themselves after proper instruction and supervision, potentially yielding better outcomes than less frequent professional dressing changes 2

Clinical Context and Supporting Evidence

Cadexomer iodine is more effective than standard dressings for infected chronic venous ulcers, with evidence showing significantly faster epithelial regrowth (p < 0.001) and greater ulcer size reduction compared to standard care 2, 3. The pooled estimate from four RCTs demonstrated that cadexomer iodine increased complete healing at 4-12 weeks with a risk ratio of 2.17 (95% CI 1.30 to 3.60) 3.

Mechanism of Action

  • Cadexomer iodine is a hydrophilic starch powder containing iodine that serves as an antimicrobial dressing suitable for granulating wounds 2
  • The preparation effectively removes pus, debris, and exudate while stimulating granulation tissue formation 4
  • It significantly reduces bacterial infection, particularly with Staphylococcus aureus and Pseudomonas aeruginosa, with correlation between time to eliminate S. aureus infection and ulcer healing rate 4

Treatment Duration and Monitoring

  • Continue treatment for up to 24 weeks or until the ulcer has healed 2
  • Mean ulcer size reduction of 71% can be expected after 6 weeks of daily cadexomer iodine application in hospitalized patients 5
  • Monitor for transient pain after application, which occurs in a small minority of patients (4 out of 93 in one trial) 4

Essential Concurrent Therapy

Compression therapy at 30-40 mmHg must be used concurrently with cadexomer iodine for venous ulcers 6, 7. Before applying compression:

  • Measure ankle-brachial index (ABI) to rule out arterial insufficiency 7
  • If ABI < 0.6, revascularization is required before any compression therapy 7
  • If ABI 0.6-0.9, reduce compression to 20-30 mmHg 7
  • If ABI > 0.9, proceed with full 30-40 mmHg compression 7

Additional Management Considerations

  • Perform aggressive surgical debridement to convert chronic wounds to acute healing wounds 7
  • Treat systemic infection with appropriate systemic antibiotics when fever, lymphangitis, lymphadenopathy, or erysipelas are present 8
  • Consider adding pentoxifylline 400 mg three times daily as an adjunct, which is more effective than placebo plus compression for complete healing (RR 1.56; 95% CI 1.14-2.13) 7

Important Caveats

Topical antimicrobial preparations like cadexomer iodine should be used for clinically infected ulcers, not merely colonized wounds 3. The evidence supports cadexomer iodine over other topical preparations including povidone-iodine, silver-based products, and honey-based preparations, which showed no significant benefit for complete healing in venous ulcers 3.

Elevation of serum protein-bound iodine may occur with large ulcers, though thyroid function tests typically show no clinically significant changes 5. This is more relevant for extensive ulcer treatment but does not contraindicate use in standard cases.

References

Research

Controlled trial of Iodosorb in chronic venous ulcers.

British medical journal (Clinical research ed.), 1985

Research

Antibiotics and antiseptics for venous leg ulcers.

The Cochrane database of systematic reviews, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Deteriorating Venous Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.